Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_assertion type Assertion NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_head.
- NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_assertion description "[A higher rate of NY-ESO-1 expression was noted in breast cancer with high histological grade and negative hormone receptor status, suggesting NY-ESO-1 as a potential tumor antigen for immunotherapy in patients with breast cancer and poor prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_provenance.
- NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_assertion evidence source_evidence_literature NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_provenance.
- NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_assertion SIO_000772 15026363 NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_provenance.
- NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_assertion wasDerivedFrom befree-20140225 NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_provenance.
- NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_assertion wasGeneratedBy ECO_0000203 NP332201.RArj9E6Sw00r5OluXkeEIwCHmgKX5vMzouIpM5rImndCg130_provenance.